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OBJECTIVE: To investigate and compare the influence of a previous history of foot ulcers on plantar pressure variables during 
gait of patients with diabetic neuropathy. 
INTRODUCTION: Foot ulcers may be an indicator of worsening diabetic neuropathy. However, the behavior of plantar pressure 
patterns over time and during the progression of neuropathy, especially in patients who have a clinical history of foot ulcers, is 
still unclear. 
METHODS: Subjects were divided into the following groups: control group, 20 subjects; diabetic neuropathy patients without 
foot ulcers, 17 subjects; and diabetic neuropathy patients with at least one healed foot ulcer within the last year, 10 subjects. Plantar 
pressure distribution was recorded during barefoot gait using the Pedar-X system. 
RESULTS: Neuropathic subjects from both the diabetic neuropathy and DNU groups showed higher plantar pressure than control 
subjects. At midfoot, the peak pressure was significantly different among all groups: control group (139.4±76.4 kPa), diabetic 
neuropathy (205.3±118.6 kPa) and DNU (290.7±151.5 kPa) (p=0.008). The pressure-time integral was significantly higher in the 
ulcerated neuropathic groups at midfoot (CG: 37.3±11.4 kPa.s; DN: 43.3±9.1 kPa.s; DNU: 68.7±36.5 kPa.s; p=0.002) and rearfoot 
(CG: 83.3±21.2 kPa.s; DN: 94.9±29.4 kPa.s; DNU: 102.5±37.9 kPa.s; p=0.048). 
CONCLUSION: A history of foot ulcers in the clinical history of diabetic neuropathy subjects influenced plantar pressure distri-
bution, resulting in an increased load under the midfoot and rearfoot and an increase in the variability of plantar pressure during 
barefoot gait. The progression of diabetic neuropathy was not found to influence plantar pressure distribution.
KEYWORDS: Biomechanics; Gait; Diabetic Neuropathies; Pressure; Foot ulcer. 
INTRODUCTION
Diabetic peripheral neuropathy (DPN) is one of the 
most common complications in the progression of diabetes 
mellitus. It is believed that approximately 50% of patients 
with diabetes will develop DPN within 10 to 15 years.1 
The course of peripheral neuropathy is a progressive 
degeneration of the peripheral nerves, especially in the 
lower limbs, that can cause sensory and motor deficits 
that affect the biomechanics of the diabetic foot, as seen 
in ankle kinematics,1-3 gait kinetics5,6 and plantar pressure 
distribution.7-10
The research literature has reported the existence of a 
strong association between diabetic neuropathy and higher 
plantar loads that may be responsible for foot ulceration11-13 
and re-ulceration.14 However, some authors have not 
found elevated peak pressures for all ulcerated patients.15 
Therefore, the coexistence of increased peak pressure and 
the pathogenesis of ulcer formation is considered speculative 
at best.7 Although re-ulceration is common in patients with 
diabetic neuropathy even with adequate footwear use,16 the 
differences in the distribution patterns of plantar pressure 
following a completely healed ulcer and its relationship 
with ulceration recurrence after one year of resolution is 114
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still unknown.
An ideal approach to study the biomechanical effects 
of diabetic neuropathy in ulcer development would be a 
long-term longitudinal study to analyze plantar pressure 
distribution during gait before and after the ulcer formation. 
A short-term option is a comparison study of two different 
groups of neuropathic patients at different stages of the 
neuropathy to address deficits in sensitivity and previous 
history of ulceration in order to predict the incidence of re-
ulceration under high plantar pressures. 
This study was based on the assumption that the presence 
of foot ulcers in the clinical history of a diabetic subject is 
a sign of worsening neuropathy because the development of 
ulceration is considered the probable result of progressive 
neurological, vascular and autonomic damage that denotes 
the advancement of the disease over time. For this reason, 
the purpose of this study was to investigate and compare 
the influence of a previous history of foot ulcers on plantar 
pressure variables during gait. We hypothesized that, even 
with healed ulcers, diabetic neuropathy patients with a 
history of ulceration would still show an altered distribution 
pattern of plantar pressure during gait when compared to 
patients who had not yet developed ulceration.
MATERIALS AND METHODS
Subjects
All subjects were informed about the procedures and 
signed a written term of free and informed consent that was 
approved by the ethics committee of the local institution. 
This cross-sectional study involved three groups: a control 
group (CG) composed of 20 asymptomatic subjects, a 
diabetic neuropathy group (DN) of 17 subjects and a diabetic 
neuropathy group with a history of previous foot ulceration 
(DNU) composed of 10 subjects. 
The diabetic population was recruited through The 
National Association for Assistance to Diabetics. The 
control group subjects were employee volunteers from the 
academic department that conducted this study. Recruiting 
to the control group was conducted in an attempt to match 
the anthropometric characteristics of the diabetic neuropathy 
patients, such as body mass, body mass index, and age 
(within a decade).
Patients in the diabetic neuropathy groups (DN and 
DNU) all had a clinical diagnosis of peripheral diabetic 
neuropathy. The inclusion criteria for both neuropathic 
groups were diabetes (type 1 or 2) with more than five 
years since onset and a score higher than six on the 
Michigan Neuropathy Screening Instrument questionnaire 
(MNSI-q) for symptoms related to the diabetic neuropathy.17 
Additionally, subjects were required to have a minimum of 
two areas where they did not feel a 10 g monofilament.15 
For inclusion in the DNU group, the patients were 
required to present a history of foot ulceration within the last 
year that was healed at the time of the evaluation. 
Subjects were not included if they were over 65 years of 
age or presented any of these conditions: hallux amputation 
or partial amputation of the foot; major foot shape alterations 
by visual inspection; orthopedic disorders of the lower limbs; 
pain during data acquisition; use of any assistive devices for 
walking (walking sticks/canes); traumatic ulceration that 
could be immediately recognized by the subject; Charcot 
arthropathy confirmed by radiography; or foot ulcers at the 
time of evaluation.
Experimental Procedures 
First, anthropometric and demographic data were 
collected and the subjects were asked whether or not they 
were diabetic, the type and duration of the disease, treatment 
received for diabetes and the results of their most recent 
glycemia test. Then, subjects answered the MNSI-q, which 
is composed of 15 questions regarding typical sensory 
symptoms of diabetic neuropathy, such as numbness, 
paresthesia, and pain and burning sensation, and has a 
maximum score of 13 points. The higher the MNSI score is, 
the more neuropathic symptoms the patients will report and 
the worse the neuropathy will be. As part of the screening 
procedures, a foot inspection was conducted by a single 
examiner in order to identify foot deformities and to assure 
similar foot shape in all groups. At this screening stage, 
tactile sensitivity was also tested as part of the inclusion 
criteria using 10 g Semmes-Weinstein monofilaments (Sorri 
Bauru®, Bauru, Brazil)18-20 on both feet in five areas of each 
plantar surface: rearfoot, midfoot, lateral forefoot (3rd to 5th 
metatarsal head), medial forefoot (1st and 2nd metatarsal 
head) and hallux. 
After initial data collection, the subjects walked on a 
10 m walkway at a controlled cadence while wearing only 
Pedar-X insoles from Novel® System (Munich, Germany) 
inside anti-skid socks as described in the literature.4 The 
insoles were 2.5 mm thick and contained a matrix of 99 
capacitive pressure sensors with a spatial resolution of 1.6 
to 2.2 cm2. Prior to the tests, the insoles were calibrated 
according to the manufacturer’s instructions, and before 
data acquisition, the zero setting procedure was performed 
as recommended by Novel.21
Before data acquisition, the subjects were instructed 
to walk freely in the laboratory to reproduce their typical 
gait and to feel comfortable at the laboratory for a period 
of approximately five minutes. A digital metronome was 115
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used to limit gait cadence to a range of 96 to 110 steps per 
minute in order to avoid large differences in gait cadence 
among trials and subjects. Gait analysis was performed in 
the barefoot condition (Pedar-X insoles inside anti-skid 
socks) to avoid the influence of compounding factors on 
plantar pressure (e.g., the subject’s own shoes). Although 
the Pedar-X system was designed for evaluating shod gait, 
it has been used previously by other authors to evaluate 
barefoot gait22. Thus, plantar pressure patterns were studied 
only by foot-floor interaction. Moreover, the Pedar X system 
allowed subjects to walk more steps while acquiring the 
data comparing with the plataform system (EMED, Novel, 
Munich). While use of the barefoot condition has a high risk 
of wound formation, the subjects’ wearing of shoes would 
introduce greater variation and variability in plantar pressure 
data. In view of the increased wound formation risk of the 
procedure, all subjects were permitted to sit between trials, 
if needed. A total of 20 steps were recorded for analysis at a 
sample rate of 50 Hz.
Numerical Analysis
We divided the plantar surface into the same five areas as 
described for plantar sensitivity evaluation. The masks used 
to analyze plantar pressure were adjusted proportionally to 
the width and length of the foot (Figure 1) and were based 
on Cavanagh’s scheme.23 The five areas and their sizes were: 
M1 rearfoot (27% of the foot length); M2 midfoot (28% of 
the foot length); M3 forefoot (25% of the foot length), which 
was divided into two areas: M4 medial forefoot (55% of the 
forefoot width) and M3 lateral forefoot (45% of the forefoot 
width); and M5 hallux (the final 20% of foot length with 
33% of the width).
The variables analyzed for each foot area were peak 
pressure (kPa) and pressure-time integral (kPa.s), as defined 
by the impulse of peak pressure over the stance phase. The 
pressure variables were calculated using the mean value 
across steps for each trial per subject (approximately 20 
steps), and then across trials per subject (approximately 
2 trials). Also, the initial and final couple of steps were 
removed to avoid acceleration and deceleration phases, 
which could influence our results. The coefficient of 
variation (CV) was calculated for each plantar pressure 
variable to represent data variability and was calculated 
as the standard deviation divided by the mean data values, 
multiplied by 100. 
Statistical Analysis
The anthropometric and demographic data were 
compared among groups using an ANOVA after the data 
distribution had been analyzed by the Shapiro Wilks Test. 
Categorical variables (e.g., gender, type of diabetes) were 
compared using Chi-squared test for multiple responses. 
Clinical variables were compared between diabetic groups 
using a Student’s t-test, and due to their ordinal nature, the 
MNSI data were compared using the Mann Whitney U-test. 
Plantar pressure data were compared among groups using 
ANOVAs when normal distribution was achieved; otherwise, 
the Kruskal Wallis test was used. The Scheffé tests (for 
parametric multiple comparisons) and Mann Whitney U-tests 
(for non-parametric multiple comparisons) were used as 
post-hoc tests when significant differences were found. An 
alpha of 5% was adopted for significant differences.
RESULTS
Demographic data and the characteristics of the subjects’ 
diabetes are shown in Table 1. 
The velocities achieved during gait trials were not 
different between groups (CG: 64.5 ± 6.8 m/min; DN: 64.0 
± 7.7 m/min; DNU: 57.5 ± 12.3 m/min; p=0.2613).
The peak pressure and pressure-time integral are 
Figure 1 - Masks created in the Creation of Any Mask software (Novel) to 
analyze plantar pressure in five plantar areas: M1 – Rearfoot; M2 – Midfoot; 
M3 – Lateral Forefoot; M4 – Medial Forefoot; M5 – Hallux.116
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shown in Table 2. Peak pressure was significantly different 
(p=0.008) among all groups for the midfoot (M2). 
Neuropathic groups presented statistically higher values than 
CG (p<0.05), and DNU presented the highest values for peak 
pressure among groups (p<0.05) (Table 2). 
Regarding the plantar-pressure integral, neuropathic 
subjects presented higher values than control subjects, 
mainly at the lateral forefoot (M3), midfoot (M2) and 
rearfoot (M1). Figure 2 represents a summary of the 
differences observed among groups in the pressure-time 
integral variable.
DNU subjects presented a higher CV of pressure data 
than the CG and DN subjects. Pressure-time integral changes 
are summarized in Figure 2. The figure of the upper foot 
represents the DN group in a comparison with the CG (black 
arrows). The bottom foot represents the DNU group in a 
comparison with CG (black arrows) and also in comparison 
to the DN group (white arrows).
Table 1 - Demographic Data: Control Group (CG), Diabetic Neuropathy (DN) and Ulcerated Diabetic Neuropathy (DNU) 
Groups
Variables CG (n=20) DN (n=17) DNU (n=10) p
Age ( in years) 1 48.7 (9.4) 54.7(7.8) 58.2 (6.7) 0.1059
BMI (kg/m2) 1 24.3 (2.6) 26.1 (4.6) 27 (5.5) 0.2445
Male (%)2 35 47 80 0.0658
Time since Onset of Diabetes ( in years) 3 _ 13.4 (8.2) 17.5 (9.3) 0.2463
Diabetes Type 2 (%)2 _ 94 90 0.6125
Mean glycemic index (mg/dL) 3 _ 147.5 (58.2) 199.3 (60.5)  0.0554
MNSI questionnaire – (median) 4 _ 7 7 0.8408
The data presented are Mean and Standard Deviation (SD), p-values, Percentage and Median; CG = control group; DN = diabetic neuropathy group; DNU 
= ulcerated diabetic neuropathy group 
1ANOVA test, 2Chi-square test, 3Student t- test, 4Mann Whitney test. 
Table 2 - Plantar pressure distribution
Plantar areas CG DN DNU p
Peak pressure (kPa)
Hallux2 306.8 (110.7)
36%
305.6 (111.7)
36%
269.6 (136.7)
50%
0.4650
Medial forefoot2 347.5 (88.4)
25%
365.4 (93.7)
25%
351.6 (92.5)
26%
0.6912
Lateral forefoot1 328.8 (67.5)
20%
367.7 (89.2)
24%
367.2 (86.2)
23%
0.1096
Midfoot1 139.4 (76.4)
54%
205.3 (118.6)
57%
290.7 (151.5)
52%
0.0008
Rearfoot1 337.4 (95.9)
28%
342.1 (76.9)
22%
342.3 (119.1)
34%
0.7438
Pressure-time Integral (kPa.s)
Hallux1 68.2 (24.5)
36%
74.3 (26.4)
35%
60.0 (24.2)
40%
0.1355
Medial forefoot2 97.9 (23.2)
23%
110.9 (26.5)
23%
110.0 (31.7)
28%
0.0403
Lateral Forefoot2 97.7 (18.4) 
18%
119.3 (31.8)
26%
125.9 (33.4)
26%
0.0003
Midfoot1 37.3 (11.4)
30%
43.3 (9.1)
21%
68.7 (36.5)
53%
0.0002
Rearfoot1 83.3 (21.2) 
25%
94.9 (29.4)
30%
102.5 (37.9)
37%
0.0486
Mean and Standard Deviations (SD) and Coefficient of Variation (%) and p-values. Control Group (CG); Diabetic Neuropathy (DN) and Ulcerated Diabetic 
Neuropathy (DNU) Groups. Bold data represent the groups that were different from each other. 1Kruskal Wallis test, 2ANOVA test.117
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DISCUSSION 
This study investigated plantar pressure distribution 
during gait, which is influenced by many factors24,25 in 
subjects at different stages of diabetic neuropathy, with 
(n=17) or without (n=10) a history of foot ulcers, as 
compared a non-diabetic control group (n=20). 
In the present paper, the presence of ulceration in the 
neuropathic clinical history was assumed to be an indicator 
of a worsening progression of neuropathy. However, the 
neuropathic groups were composed of diabetics with similar 
disease characteristics (p>0.05) according to the duration of 
disease, type of diabetes and diabetic neuropathy symptoms 
(MNSI). Although the length of disease since onset was 
not significantly different, the ulcerated group had a higher 
mean. It has long been known that diabetic neuropathy is a 
chronic consequence of diabetes mellitus and that the risk of 
ulceration increases with time.1 
It  was  expected  that  diabetics  with  advanced 
complications due to neuropathy, such as a history of 
foot ulceration, would present more severe symptoms, but 
this was not confirmed by MNSI scores. Therefore, the 
assumption that the presence of ulcers is an indicator of 
a worsening progression of neuropathy is not relevant. In 
addition, it is already known that good foot care, including 
daily foot inspection, moisturizing, and appropriate footwear, 
may prevent ulceration even in the presence of severe 
neuropathy. Other factors such as sensorial, autonomic and 
motor dysfunctions may be related to the pathogenesis of 
ulceration. 
The ulcerated diabetic patients may have already 
developed autonomic and vascular deficits that were not 
evaluated by the MNSI in this study, but that could have 
contributed greatly to ulcer formation. The authors recently 
discussed the lack of significant differences with regard to 
symptoms between diabetic neuropathic populations with 
and without a clinical history of foot ulceration.26 Other 
findings, such as nerve conduction velocity and sensory 
tests, were able to differentiate both populations in the same 
study. Moreover, development of foot ulceration has been 
strongly associated with the loss of protective sensations in 
the diabetic foot.7,19,26,27 
The neuropathy groups presented significantly higher 
values of peak pressures under the midfoot and pressure-
time integrals under all plantar areas except under the 
hallux (Table 2). Some studies have shown changes in 
plantar pressure distribution patterns following induction of 
plantar insensitivity.28-30 In this study, the loss of protective 
sensation was not transitory as found by others authors,28,30 
but was present in the neuropathic subjects and may explain 
the higher plantar loads found when compared to non-
neuropathic subjects.
Comparing both neuropathic groups, the ulcerated 
subjects showed higher peak pressures under the midfoot 
and pressure-time integrals under the midfoot and rearfoot. 
The Charcot condition was excluded in the neuropathic 
subjects, and this absence was confirmed by radiographic 
examination; thus, the higher peak pressure at the midfoot 
in ulcerated diabetics may not be associated with either the 
Charcot condition or the dropped longitudinal arch among 
neuropathic subjects. All subjects from the three groups 
presented an arch index classified as normal.31 The higher 
peak pressure under the midfoot can be explained by the 
shift of the loading pattern from the lateral toward the medial 
part of the foot and from the rearfoot to the anterior part of 
the foot at the roll over process, which is even more evident 
in ulcerated patients.32 Additionally, as noted previously, 
compensatory musculoskeletal mechanisms developed in 
neuropathic patients to compensate for their sensory deficit, 
altering the foot roll over mechanism.33
It is important to point out other factors that interfere 
with plantar pressure distribution, such as foot deformities34 
and mobility of the foot and ankle joint complex.35-37 Diabetic 
neuropathy causes a progressive alteration in muscle 
trophism, especially in the intrinsic foot/ankle muscles, an 
increase in joint rigidity, and an alteration of the collagen 
structure in the fasciae and muscle tendons due to collagen 
crosslinking and non-enzymatic glycosylation of keratin. 
This means that muscles, cartilage, tendons and ligaments 
will have their structures changed, which will culminate in 
a limitation of foot mobility.35,36,38 This study did not assess 
the compounding variable of joint mobility. However, we 
Figure 2 – Summary of differences in pressure-time integral according to 
its tendency. Upper panel presentation: comparison between DN and CG 
(black arrows), showing higher values for DN. Lower panel: comparison 
between DNU and CG (black arrows) and to DN (white arrows). Black stars 
represent significant differences (p<0.05) between groups.118
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did exclude subjects with apparent foot deformity or Charcot 
arthropathy confirmed by radiography. Furthermore, the 
literature is not yet clear regarding the relationship between 
the smaller passive and/or dynamic ankle range of motion 
and higher plantar pressures, since a recent study showed 
that despite a significant reduction in the passive range of 
motion at the ankle joint complex in diabetic subjects, the 
gait range of motion was indistinguishable from that of 
control subjects and was not correlated with plantar pressure 
variables.39 
Alterations of plantar pressure distribution at the midfoot 
were also detected in a recent study40 showing a possible 
presence of polymorphism that could not be detected by 
static radiographies. The subjects evaluated in the present 
study did not have Charcot arthropathy, but the lateral 
column of the midfoot could be responsible for raising the 
loads over their midfoot.40
Although there are other factors that can affect plantar 
pressure distribution, the present study focused on one 
particular aspect of this chain on plantar pressure alteration: 
neuropathy progression with the presence of at least one 
ulcer in the patient’s clinical history. It was observed that this 
factor interferes in the pressure pattern distribution. DNU 
subjects presented a worse load distribution pattern during 
gait, overloading the midfoot and the rearfoot. These changes 
could be associated with foot ulcer pathogenesis or could be 
an additional alteration after ulcer healing that worsens the 
biomechanical condition of these patients and their clinical 
consequences. 
The values of plantar pressures found for all areas for 
each experimental group were not considered to be a risk 
for foot ulceration based on the thresholds described in the 
literature: 600 kPa,15,41 1000 kPa42 and 1230 kPa.14 However, 
diabetic neuropathic patients can develop ulceration even 
under normal plantar pressure values.1 This factor becomes 
more important when the biomechanical condition of 
ulcerated patients is considered.
The cumulative plantar tissue stress was estimated in 
subjects with diabetic peripheral neuropathy with a history 
of recurrent ulcers. Surprisingly, it was shown that these 
patients had lower daily cumulative plantar tissue stress as 
compared to neuropathic subjects who had never developed 
a foot ulcer.27 Authors have suggested that after an initial 
episode of skin breakdown, plantar tissue may become 
more susceptible to future lesions as a result of disuse 
atrophy following treatment of the first episode, so that 
plantar tissues re-ulcerate even under low stress.27 Thus, 
the ulcerated subjects in this study may be predisposed to 
re-ulceration due to their poor biomechanical condition in 
comparison to the non-ulcerated group. 
More alterations in plantar pressure variables were 
expected than our findings showed. A possible explanation 
for the lower observed alteration may be that the diabetic 
patients evaluated may have learned conservational motor 
strategies for gait (e.g., changing from ankle to hip use to 
achieve shorter applications of force in the ankle complex,2 
minimizing plantar loads. Another possible strategy to 
minimize plantar loads that can be adopted by neuropathic 
subjects is the redistribution of loads from the more 
insensate areas to the more sensate, as already described in 
the litarature.28 
Notably, the pressure-time integral was the variable 
that was the most different among groups (Table 2). The 
pressure-time integral was able to distinguish the neuropathic 
groups from the control group in all areas studied and to 
distinguish the neuropathic groups from each other in two 
out of five areas. This variable may be related to neuropathy 
progression deficits, and greater changes in this variable 
may be expected in accordance with the progression of 
neuropathy. Others6,43-45 have reported this variable as a 
better parameter to evaluate the concept of load than peak 
pressure, which for the last two decades has been the only 
biomechanical variable associated with ulcer formation. 
The pressure-time integral provides an indication of plantar 
loading behavior over time, and the present study suggests 
a different mechanism for load absorption and distribution 
in the neuropathic subjects resulting in a non-homogeneous 
pattern for all plantar areas, as has been observed in the 
literature.32 Furthermore, the presence of elevated plantar 
pressure shown by the pressure-time integral can also be 
associated with other orthopedic and kinesiological factors, 
such as foot and ankle joint deformities and mobility, which 
were not the focus of the present study. 
Similar coefficients of variation (Table 2) were found 
by other authors,41 where diabetic neuropathy patients did 
not show higher loading variability when compared to 
control subjects. However, in agreement with another study 
that showed higher CVs in neuropathic patients with more 
advanced neuropathy progression,33 this study demonstrated 
that the group with a previous history of ulceration (DNU) 
presented higher variability in plantar pressure distribution 
in comparison to both the neuropathic group without a 
history of ulceration (DN) and the control group. As the 
higher variability was more evident at the rearfoot and 
hallux, we conclude that more stability and motor control are 
required at the beginning and end of the support phase, and 
this higher variability may represent an attempt to improve 
compensations in motor control caused by alterations in gait 
due to external and internal changes.46 
The existence of a statistical type II error must be 
considered, especially because of the sample size of the 
ulcerated group (n = 10). It is important to highlight that 119
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during all clinic visits to recruit our neuropathic patients, 
neuropathic subjects with a history of healed ulceration 
were heavily outnumbered by patients presenting unhealed 
wounds and amputation, reflecting the poor quality of 
diabetes care and follow-up. 
Neuropathic subjects with no history of foot ulcers 
represent patients at an earlier stage of neuropathy than 
those with a history of foot ulcers. Considering this fact, 
neuropathy itself first alters plantar pressure distribution, 
then the ulcers occur, and after healing, the dynamic pattern 
remains altered and worsens plantar load distribution, 
predisposing patients to re-ulceration. 
CONCLUSIONS
The present investigation shows that neuropathic groups, 
both non-ulcerated and ulcerated, presented alterations in 
plantar pressure distribution patterns, and the ulcerated 
patients presented higher loads than non-ulcerated. The 
history of foot ulcers in the clinical history of the diabetic 
neuropathy subjects influenced plantar pressure distribution, 
resulting in an increased load under the midfoot and rearfoot 
and an increase in the variability of plantar pressure during 
barefoot gait. Progression of diabetic neuropathy could not 
be explained in this study as influencing plantar pressure 
distribution, as the groups presented the same clinical signs 
and symptoms of diabetic neuropathy.
Further longitudinal studies to investigate the presence 
of other predictive factors for foot ulceration in both 
neuropathic groups, such as footwear, foot and ankle joint 
mobility, foot deformities and autonomic and vascular 
deficits, would contribute to a better understanding of the 
development of foot ulceration. This knowledge could 
prevent initial or recurrent foot ulceration in patients with 
diabetic neuropathy. 
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